“The Dreamin’ Kind” is Langhorne Slim’s ninth studio album and finds the Pennsylvania-born, Nashville-based artist strapping on an electric guitar and embracing his longtime love of larger-than-life ...

In her Tuesday newsletter, Lily Belli notes a reshuffling at downtown Santa Cruz's Abbott Square Market, reviews the new ...

Business owners Michael Spadafora and Patrice Boyle reflect on a tumultuous year for their businesses as the Murray Street ...

Eli Lilly and Co.’s career website this month listed 254 job openings in Indianapolis and another 90 in nearby Lebanon, accounting for more than three-quarters of the 445 open positions the ...

Eli Lilly (LLY) submitted an FDA application for orforglipron. The once-daily oral pill maintained weight loss after patients switched from injections. Lilly’s Zepbound achieved 20.2% average weight ...

The Edmonds-Woodway High School Jazz Ensemble I has been to be selected for 2026 Starbucks Hot Java Cool Jazz concert, EWHS ...

Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the company's lead in this niche of the industry. Even after their strong run, Lilly's ...

BUY MERCH AT PLAY ON THE NEW MINECRAFT SERVER JAVA EDITION IP Address: play.gamersreact.net SUBMIT CLIPS: Discord twitter instagram tik tok @gamersreactyt Background Music: "Night out" by LiQWYD ...

One of Eli Lilly’s most promising new obesity drugs helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis. The drug giant’s LLY stock was ...

Patients on Eli Lilly’s next-generation obesity shot lost nearly 30% of their body weight on average in a trial that tracked them for a little more than a year—a result that’s far better than the most ...

A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...